|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000168899 |
Summary for VAMP5 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000168899 | Gene symbol | VAMP5 |
| Gene name | vesicle associated membrane protein 5 | |
| HGNC | 12646 | |
| Entrez ID | 10791 | |
| Gene type | protein_coding | |
| Synonyms | VAMP5| | |
| UniProtAcc | O95183 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for VAMP5 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for VAMP5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for VAMP5 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg02652597 | chr2:85584169 | CGI:chr2:85584217-85584732 | promoter | 4.49e-01 | 5.76e-01 | -2.91e+00 | 3.59e-03 | 1.79e-02 | -1.27e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg16719560 | chr2:85584298 | CGI:chr2:85584217-85584732 | promoter | 4.72e-01 | 3.67e-01 | 3.33e+00 | 8.54e-04 | 1.70e-03 | 1.05e-01 |
| HNSC | cg19513321 | chr2:85584309 | CGI:chr2:85584217-85584732 | promoter | 2.72e-01 | 9.92e-02 | 2.12e+00 | 3.40e-02 | 3.61e-02 | 1.73e-01 |
| LUSC | cg19513321 | chr2:85584309 | CGI:chr2:85584217-85584732 | promoter | 3.98e-01 | 9.96e-02 | 3.16e+00 | 1.60e-03 | 3.58e-03 | 2.99e-01 |
| LUSC | cg16865965 | chr2:85584539 | CGI:chr2:85584217-85584732 | promoter,gene body | 5.25e-01 | 4.08e-01 | 2.83e+00 | 4.71e-03 | 7.80e-03 | 1.17e-01 |
| LUSC | cg23902361 | chr2:85583721 | CGI:chr2:85584217-85584732 | promoter | 6.72e-01 | 5.40e-01 | 3.67e+00 | 2.39e-04 | 1.07e-03 | 1.33e-01 |
| LUSC | cg02652597 | chr2:85584169 | CGI:chr2:85584217-85584732 | promoter | 3.23e-01 | 1.69e-01 | 3.24e+00 | 1.21e-03 | 2.96e-03 | 1.54e-01 |
| LUSC | cg16719560 | chr2:85584298 | CGI:chr2:85584217-85584732 | promoter | 4.84e-01 | 3.28e-01 | 2.99e+00 | 2.82e-03 | 5.35e-03 | 1.56e-01 |
| LUSC | cg11108890 | chr2:85584348 | CGI:chr2:85584217-85584732 | promoter | 4.47e-01 | 3.02e-01 | 3.01e+00 | 2.65e-03 | 5.12e-03 | 1.45e-01 |
| LUSC | cg25651505 | chr2:85584900 | CGI:chr2:85584217-85584732 | promoter,gene body | 4.72e-01 | 3.48e-01 | 2.53e+00 | 1.13e-02 | 1.52e-02 | 1.24e-01 |
| COAD | cg25651505 | chr2:85584900 | CGI:chr2:85584217-85584732 | promoter,gene body | 3.75e-01 | 4.77e-01 | -2.56e+00 | 1.03e-02 | 1.47e-02 | -1.02e-01 |
| BLCA | cg19513321 | chr2:85584309 | CGI:chr2:85584217-85584732 | promoter | 3.31e-01 | 9.32e-02 | 2.40e+00 | 1.64e-02 | 2.09e-02 | 2.38e-01 |
| BLCA | cg02493740 | chr2:85583621 | CGI:chr2:85584217-85584732 | promoter | 6.89e-01 | 8.15e-01 | -2.87e+00 | 4.10e-03 | 6.95e-03 | -1.26e-01 |
| LIHC | cg25651505 | chr2:85584900 | CGI:chr2:85584217-85584732 | promoter,gene body | 1.77e-01 | 2.85e-01 | -6.14e+00 | 8.51e-10 | 1.15e-08 | -1.08e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg19513321 | chr2:85584309 | CGI:chr2:85584217-85584732 | promoter | 5.39e-01 | 3.09e-01 | 1.02e+01 | 2.10e-24 | 1.68e-23 | 2.29e-01 |
| BRCA | cg16865965 | chr2:85584539 | CGI:chr2:85584217-85584732 | promoter,gene body | 6.32e-01 | 4.42e-01 | 1.04e+01 | 3.96e-25 | 3.41e-24 | 1.90e-01 |
| BRCA | cg02652597 | chr2:85584169 | CGI:chr2:85584217-85584732 | promoter | 4.49e-01 | 2.70e-01 | 1.11e+01 | 1.56e-28 | 1.91e-27 | 1.78e-01 |
| BRCA | cg16719560 | chr2:85584298 | CGI:chr2:85584217-85584732 | promoter | 5.98e-01 | 4.19e-01 | 9.87e+00 | 5.52e-23 | 3.88e-22 | 1.79e-01 |
| BRCA | cg11108890 | chr2:85584348 | CGI:chr2:85584217-85584732 | promoter | 5.56e-01 | 3.95e-01 | 9.70e+00 | 2.98e-22 | 1.96e-21 | 1.61e-01 |
| BRCA | cg25651505 | chr2:85584900 | CGI:chr2:85584217-85584732 | promoter,gene body | 5.84e-01 | 4.24e-01 | 1.00e+01 | 1.14e-23 | 8.57e-23 | 1.59e-01 |
Top |
Exon skipping events with PSI in TCGA for VAMP5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for VAMP5 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for VAMP5 |
| TFs related to VAMP5. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| GBM | GTF3A | VAMP5 | 2.71e+00 | 4.66e-03 | 4.05e+00 | 9.82e-01 | Female-biased |
| GBM | HINFP | VAMP5 | 2.16e+00 | 1.45e-03 | 3.94e+00 | 9.82e-01 | Female-biased |
| GBM | KLF17 | VAMP5 | 2.07e+00 | 1.03e-03 | 3.97e+00 | 9.83e-01 | Female-biased |
| GBM | TFAP2A | VAMP5 | 2.28e+00 | 1.55e-03 | 4.04e+00 | 9.85e-01 | Female-biased |
| GBM | TFAP2B | VAMP5 | 2.44e+00 | 1.76e-03 | 4.16e+00 | 9.88e-01 | Female-biased |
| GBM | TFAP2C | VAMP5 | 2.39e+00 | 1.75e-03 | 4.10e+00 | 9.86e-01 | Female-biased |
| GBM | TFAP4 | VAMP5 | 2.63e+00 | 3.82e-03 | 4.04e+00 | 9.83e-01 | Female-biased |
| GBM | ZNF141 | VAMP5 | 1.91e+00 | 2.77e-04 | 4.21e+00 | 9.90e-01 | Female-biased |
| GBM | ZNF19 | VAMP5 | 2.66e+00 | 4.29e-03 | 4.04e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF2 | VAMP5 | 2.24e+00 | 9.79e-04 | 4.16e+00 | 9.89e-01 | Female-biased |
| GBM | ZNF415 | VAMP5 | 2.25e+00 | 1.77e-03 | 3.95e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF431 | VAMP5 | 2.65e+00 | 4.21e-03 | 4.03e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF460 | VAMP5 | 1.92e+00 | 7.58e-04 | 3.92e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF483 | VAMP5 | 2.37e+00 | 2.31e-03 | 3.98e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF524 | VAMP5 | 3.16e+00 | 9.69e-03 | 4.22e+00 | 9.81e-01 | Female-biased |
| GBM | ZNF616 | VAMP5 | 2.68e+00 | 3.52e-03 | 4.13e+00 | 9.85e-01 | Female-biased |
| GBM | ZNF619 | VAMP5 | 2.08e+00 | 9.18e-04 | 4.02e+00 | 9.85e-01 | Female-biased |
| GBM | ZNF669 | VAMP5 | 3.17e+00 | 5.26e-03 | 4.48e+00 | 9.89e-01 | Female-biased |
| GBM | ZNF682 | VAMP5 | 2.46e+00 | 2.73e-03 | 4.00e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF684 | VAMP5 | 3.06e+00 | 7.45e-03 | 4.22e+00 | 9.83e-01 | Female-biased |
| GBM | ZNF69 | VAMP5 | 2.89e+00 | 4.75e-03 | 4.22e+00 | 9.86e-01 | Female-biased |
| VAMP5 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for VAMP5 |
| RBPs related to ES in VAMP5. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| VAMP5 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9309594 | chr2:82123762:A:G | - | -0.188152374067228 | 0.0291904751821529 | HNSC | Female-baised eQTL |
| rs6547406 | chr2:82142235:A:C | - | -0.182369406787073 | 0.0333809192025686 | HNSC | Female-baised eQTL |
| rs6547407 | chr2:82142258:G:T | - | -0.182369406787073 | 0.0333809192025686 | HNSC | Female-baised eQTL |
| rs1521664 | chr2:82144365:A:G | - | -0.182369406787073 | 0.0333809192025686 | HNSC | Female-baised eQTL |
| rs4852214 | chr2:82145144:G:T | - | -0.182369406787073 | 0.0333809192025686 | HNSC | Female-baised eQTL |
| rs2163360 | chr2:82093214:G:A | - | -0.18066193494345 | 0.0385052191829908 | HNSC | Female-baised eQTL |
| rs76504025 | chr2:81739245:T:C | - | 0.121289551385144 | 0.0358469998173763 | LUSC | Female-baised eQTL |
| rs80202736 | chr2:81741589:G:A | - | 0.120724702050107 | 0.0375834021732235 | LUSC | Female-baised eQTL |
| rs6705751 | chr2:79007114:G:A | - | -0.0905929083242961 | 0.0125913039258901 | KIRC | Female-baised eQTL |
| rs10520223 | chr2:79001131:A:G | - | -0.0881985438010196 | 0.0227654289794565 | KIRC | Female-baised eQTL |
| rs7565752 | chr2:79000633:T:C | - | -0.0864103381466878 | 0.0237149250138921 | KIRC | Female-baised eQTL |
| rs17016049 | chr2:79001024:T:C | - | -0.0866240009622682 | 0.0274643973357443 | KIRC | Female-baised eQTL |
| rs11126692 | chr2:79003148:G:T | - | -0.0824660289162245 | 0.0447492101559397 | KIRC | Female-baised eQTL |
| rs12617493 | chr2:79005451:G:A | - | -0.0824660289162245 | 0.0447492101559397 | KIRC | Female-baised eQTL |
| rs5002167 | chr2:79002696:G:T | - | -0.0841898144322724 | 0.0498190280280935 | KIRC | Female-baised eQTL |
| rs5002168 | chr2:79002706:A:C | - | -0.0841898144322724 | 0.0498190280280935 | KIRC | Female-baised eQTL |
| rs5002169 | chr2:79002710:C:T | - | -0.0841898144322724 | 0.0498190280280935 | KIRC | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs62149760 | chr2:81822501:G:A | - | 0.0861414862437167 | 2.45484537334757e-06 | LUSC | Male-baised eQTL |
| rs62153174 | chr2:81794052:G:C | - | 0.0767296007228092 | 4.12768169028144e-05 | LUSC | Male-baised eQTL |
| rs62153175 | chr2:81809778:C:T | - | 0.0767296007228092 | 4.12768169028144e-05 | LUSC | Male-baised eQTL |
| rs11695750 | chr2:81784653:C:A | - | 0.0778450737634372 | 4.77562813462586e-05 | LUSC | Male-baised eQTL |
| rs11695849 | chr2:81784839:C:T | - | 0.0778450737634372 | 4.77562813462586e-05 | LUSC | Male-baised eQTL |
| rs17020755 | chr2:81792256:G:C | - | 0.0778300128006651 | 4.86392062324053e-05 | LUSC | Male-baised eQTL |
| rs62153172 | chr2:81777494:A:T | - | 0.0698498852281399 | 0.000467740113243799 | LUSC | Male-baised eQTL |
| rs62149794 | chr2:81921892:C:G | - | 0.0610844670607781 | 0.0045142356091029 | LUSC | Male-baised eQTL |
| rs62149795 | chr2:81921991:A:G | - | 0.0610844670607781 | 0.0045142356091029 | LUSC | Male-baised eQTL |
| rs62149798 | chr2:81935119:T:C | - | 0.0594604432264496 | 0.0067244472441323 | LUSC | Male-baised eQTL |
| rs10520307 | chr2:81943650:T:C | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs62149799 | chr2:81944696:A:G | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs141430405 | chr2:81945557:T:G | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs78956882 | chr2:81946213:T:C | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs115905933 | chr2:81946616:G:A | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs78268192 | chr2:81949827:C:T | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs62149819 | chr2:81953076:A:G | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs45552344 | chr2:81953357:T:C | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs62149821 | chr2:81956420:G:A | - | 0.0589708704445802 | 0.0078426536620768 | LUSC | Male-baised eQTL |
| rs62149822 | chr2:81958050:C:T | - | 0.0536389021401696 | 0.0245443359273551 | LUSC | Male-baised eQTL |
| rs62149824 | chr2:81962314:C:A | - | 0.0536389021401696 | 0.0245443359273551 | LUSC | Male-baised eQTL |
| rs995108 | chr2:81968234:T:C | - | 0.0535003145701731 | 0.0255060273491239 | LUSC | Male-baised eQTL |
| rs62141662 | chr2:82140967:G:T | - | 0.0553411222983255 | 0.0477411215135852 | LUSC | Male-baised eQTL |
| rs10187314 | chr2:85701427:C:T | - | 0.022579919661763 | 0.033322706597362 | KIRC | Male-baised eQTL |
| rs10210321 | chr2:85701005:A:C | - | 0.0219739065608245 | 0.0408216452971754 | KIRC | Male-baised eQTL |
| rs10187164 | chr2:85701086:G:C | - | 0.0219447751477534 | 0.0442757920853069 | KIRC | Male-baised eQTL |
| rs1437745 | chr2:85701160:A:G | - | 0.0219447751477534 | 0.0442757920853069 | KIRC | Male-baised eQTL |
| rs59832218 | chr2:85700612:G:C | - | 0.0219958256112624 | 0.0452633148053868 | KIRC | Male-baised eQTL |
| rs75104694 | chr2:82459053:T:C | - | 0.115803221672414 | 0.000877275120568552 | LUAD | Male-baised eQTL |
| rs62139884 | chr2:82485227:G:A | - | 0.0863458800612081 | 0.0125894446589247 | LUAD | Male-baised eQTL |
| rs62140910 | chr2:82323792:A:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62140911 | chr2:82326458:C:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62140914 | chr2:82326601:C:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62140915 | chr2:82327880:A:T | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs4266043 | chr2:82333593:A:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138560 | chr2:82337886:A:T | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs17021642 | chr2:82346424:C:T | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138563 | chr2:82352971:A:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138564 | chr2:82356169:A:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138565 | chr2:82356353:T:C | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs114260127 | chr2:82362526:G:C | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138570 | chr2:82370032:A:G | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138571 | chr2:82370590:G:T | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs62138572 | chr2:82373203:T:C | - | 0.101550291685704 | 0.0152442433368922 | LUAD | Male-baised eQTL |
| rs7423205 | chr2:82325697:G:A | - | 0.101505872735402 | 0.0154222746708417 | LUAD | Male-baised eQTL |
| rs62139873 | chr2:82473500:C:G | - | 0.100677466185007 | 0.0173751642778787 | LUAD | Male-baised eQTL |
| rs62138633 | chr2:82455433:T:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62138634 | chr2:82455779:A:G | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62138635 | chr2:82455858:T:G | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs77792391 | chr2:82457494:A:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs17021797 | chr2:82469712:A:G | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139870 | chr2:82472600:C:T | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139872 | chr2:82473287:G:A | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs17021810 | chr2:82473574:C:G | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs75059134 | chr2:82474695:C:T | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139880 | chr2:82481483:A:G | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs77969628 | chr2:82483234:C:A | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139882 | chr2:82484819:G:A | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139883 | chr2:82484911:A:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs17021861 | chr2:82498344:T:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139922 | chr2:82498943:G:A | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139923 | chr2:82502336:G:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139925 | chr2:82503816:G:A | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139926 | chr2:82506341:A:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139927 | chr2:82506356:T:C | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs62139928 | chr2:82506814:A:G | - | 0.10003129780191 | 0.0189070810855212 | LUAD | Male-baised eQTL |
| rs76981525 | chr2:82483110:C:T | - | 0.100001135984792 | 0.0193996431065295 | LUAD | Male-baised eQTL |
| rs62138568 | chr2:82362271:C:A | - | 0.100386294171842 | 0.0212209509069361 | LUAD | Male-baised eQTL |
| rs62139754 | chr2:82274068:G:A | - | 0.0977585714678068 | 0.026793493615642 | LUAD | Male-baised eQTL |
| rs62139755 | chr2:82275634:G:A | - | 0.0977585714678068 | 0.026793493615642 | LUAD | Male-baised eQTL |
| rs62139756 | chr2:82276266:C:T | - | 0.0977585714678068 | 0.026793493615642 | LUAD | Male-baised eQTL |
| rs62139758 | chr2:82277176:T:G | - | 0.0977585714678068 | 0.026793493615642 | LUAD | Male-baised eQTL |
| rs62139751 | chr2:82269494:C:T | - | 0.0958513769989852 | 0.0293345545957879 | LUAD | Male-baised eQTL |
| rs62139752 | chr2:82270016:G:A | - | 0.0958513769989852 | 0.0293345545957879 | LUAD | Male-baised eQTL |
| rs113897971 | chr2:82270883:C:T | - | 0.0958513769989852 | 0.0293345545957879 | LUAD | Male-baised eQTL |
| rs62139753 | chr2:82270956:A:G | - | 0.0958513769989852 | 0.0293345545957879 | LUAD | Male-baised eQTL |
| rs76714967 | chr2:82272000:G:T | - | 0.0958513769989852 | 0.0293345545957879 | LUAD | Male-baised eQTL |
| rs7426288 | chr2:82278726:T:C | - | 0.0958513769989852 | 0.0293345545957879 | LUAD | Male-baised eQTL |
| rs62138736 | chr2:82560575:T:C | - | 0.0725952271387139 | 0.0342691981609987 | LUAD | Male-baised eQTL |
| rs113538524 | chr2:82564705:A:G | - | 0.0725952271387139 | 0.0342691981609987 | LUAD | Male-baised eQTL |
| rs12151733 | chr2:82318442:A:T | - | 0.0901997508362724 | 0.0397754986000263 | LUAD | Male-baised eQTL |
| rs62138686 | chr2:82531372:T:C | - | 0.0796387061438151 | 0.0410226061394044 | LUAD | Male-baised eQTL |
| rs62140899 | chr2:82299697:G:C | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs62140900 | chr2:82300719:G:T | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs62140901 | chr2:82301767:T:C | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs115492111 | chr2:82301871:A:C | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs78964099 | chr2:82301969:G:A | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs62140902 | chr2:82303051:T:A | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs74715924 | chr2:82303556:G:A | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs76197821 | chr2:82303806:A:C | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs62140905 | chr2:82310504:C:T | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs74478739 | chr2:82312148:C:G | - | 0.0898223405764169 | 0.0419709972791472 | LUAD | Male-baised eQTL |
| rs4853325 | chr2:77596716:G:A | - | 0.0981686334353682 | 9.7523978685754e-05 | COAD | Male-baised eQTL |
| rs151071255 | chr2:77610532:C:A | - | 0.0718743154343661 | 0.00251713426699541 | COAD | Male-baised eQTL |
| rs77929973 | chr2:77578181:G:A | - | 0.0738643392494474 | 0.00316158442891609 | COAD | Male-baised eQTL |
| rs77697047 | chr2:77576166:C:G | - | 0.0736749079215546 | 0.00330939022629781 | COAD | Male-baised eQTL |
| rs114118795 | chr2:77583338:C:T | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs78891248 | chr2:77583480:C:G | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs113639053 | chr2:77585203:C:T | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs75971587 | chr2:77586650:A:G | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs7563418 | chr2:77593146:C:T | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs7563716 | chr2:77593322:G:A | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs189907299 | chr2:77598397:G:T | - | 0.06909515827688 | 0.00400224645453263 | COAD | Male-baised eQTL |
| rs75327349 | chr2:77555167:A:C | - | 0.0716671764624664 | 0.0071145953480804 | COAD | Male-baised eQTL |
| rs11126620 | chr2:77555755:T:A | - | 0.0716671764624664 | 0.0071145953480804 | COAD | Male-baised eQTL |
| rs77179116 | chr2:77543046:C:G | - | 0.0655155308114569 | 0.0245627129468626 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000168899 |
| CpG Site: cg08755026 | |
| Position to Gene: gene | |
| Male Effect: -0.229933519034757 | |
| Female Effect: - | |
 | Gene ID: ENSG00000168899 |
| CpG Site: cg25651505 | |
| Position to Gene: gene,promoter | |
| Male Effect: - | |
| Female Effect: -0.436570663286543 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg08755026 | chr2:85592491 | gene | -0.229933519034757 | 6.96537268288773e-07 | -0.37905872041694827 | 4.961367131954501e-09 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg25651505 | chr2:85584900 | gene,promoter | -0.436570663286543 | 1.96201204443462e-11 | -0.4669135798097971 | 2.4156499443067174e-14 | LGG |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of VAMP5 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
